The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
ItRECIST adapted efficacy assessment in solid tumors treated with intratumoral immunotherapy.
 
Honey Kumar Oberoi
No Relationships to Disclose
 
Xavier Serres-Créixams
No Relationships to Disclose
 
Guzman Alonso
No Relationships to Disclose
 
Ignacio Matos
No Relationships to Disclose
 
Alberto Hernando-Calvo
Travel, Accommodations, Expenses - Kyowa Kirin International; Merck Serono
 
Eva Muñoz-Couselo
Consulting or Advisory Role - Bristol-Myers Squibb; MSD Oncology; Novartis; Pierre Fabre; Roche; Sanofi
Speakers' Bureau - Bristol-Myers Squibb; MSD Oncology; Novartis; Pierre Fabre
 
Marc Diez
No Relationships to Disclose
 
Iosune Baraibar
No Relationships to Disclose
 
Maria Vieito
No Relationships to Disclose
 
Maria Vieito
Consulting or Advisory Role - Debiopharm Group; Roche; TFS
Travel, Accommodations, Expenses - Roche
 
Omar Saavedra Santa Gadea
Travel, Accommodations, Expenses - Kyowa Kirin International; MSD
 
Vladimir Galvao
Travel, Accommodations, Expenses - Roche
 
Gemma Mur-Bonet
No Relationships to Disclose
 
Guillem Cunill-Macià
No Relationships to Disclose
 
Mafalda Oliveira
Honoraria - Novartis; Roche; Seagen
Consulting or Advisory Role - AstraZeneca; GlaxoSmithKline; Puma Biotechnology; Roche/Genentech; Seagen
Research Funding - AstraZeneca (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Cascadian Therapeutics (Inst); GlaxoSmithKline (Inst); Immunomedics (Inst); Novartis (Inst); Piqur (Inst); Puma Biotechnology (Inst); Roche/Genentech (Inst); Sanofi (Inst); Seagen (Inst); Zenith Epigenetics (Inst)
Travel, Accommodations, Expenses - Eisai; Novartis; Roche
 
Enriqueta Felip
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; Bayer; Blueprint Medicines; Boehringer Ingelheim; Bristol Myers Squibb; Genzyme; GlaxoSmithKline; Janssen; Lilly; Merck Serono; MSD Oncology; Novartis; Pfizer; Puma Biotechnology; Roche; Sanofi; Takeda
Speakers' Bureau - AstraZeneca; Boehringer Ingelheim; Bristol Myers Squibb; CME outfitters; Lilly; Medscape; Merck Sharp & Dohme; Novartis; PeerVoice; Pfizer; Prime Oncology; Roche; Springer; Takeda; touchIME
Research Funding - EMD Serono (Inst); Merck (Inst)
Other Relationship - GRÍFOLS
 
Teresa Macarulla
Consulting or Advisory Role - AstraZeneca; Baxalta; Baxter; Celgene; Eisai; Genzyme; Incyte; Ipsen; Lilly; Menarini; MSD; Polaris; Prime Oncology; QED Therapeutics; Roche; Sanofi/Aventis; SERVIER; Shire; Surface Oncology
Research Funding - Agios (Inst); ASLAN Pharmaceuticals (Inst); AstraZeneca (Inst); Bayer (Inst); Celgene (Inst); Genentech (Inst); Halozyme (Inst); Immunomedics (Inst); Lilly (Inst); Merrimack (Inst); Millennium (Inst); Novartis (Inst); Novocure (Inst); Pfizer (Inst); Pharmacyclics (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Celgene; H3 Biomedicine; Merck; Sanofi; SERVIER
 
Elena Elez
Honoraria - Abbvie/Genentech (Inst); Amgen (Inst); Array BioPharma; AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb; GlaxoSmithKline (Inst); Merck Serono; MSD (Inst); Novartis (Inst); Roche; Sanofi/Aventis; SERVIER
Consulting or Advisory Role - Amgen; Array BioPharma; Bayer; Bristol Myers Squibb; Merck Serono; Roche; Sanofi; SERVIER
Research Funding - Amgen; Array BioPharma (Inst); Bristol-Myers Squibb (Inst); Merck Serono; Roche (Inst); Sanofi/Aventis (Inst); SERVIER (Inst)
Travel, Accommodations, Expenses - Amgen; Array BioPharma; Bristol-Myers Squibb; Merck Serono; Roche; Sanofi; SERVIER
 
Josep Tabernero
Consulting or Advisory Role - Array BioPharma; AstraZeneca; Avvinity; Bayer; Boehringer Ingelheim; Chugai Pharma; Daiichi Sankyo; F. Hoffmann LaRoche; Genentech; HalioDx; Hutchison MediPharma; Ikena Oncology; IQvia; Lilly; Menarini; Merck Serono; Merus; Mirati Therapeutics; MSD; Neophore; Novartis; Orion Biotechnology; Peptomyc; Pfizer; Pierre Fabre; Samsung Bioepis; Sanofi; Seagen; Servier; Taiho Pharmaceutical; Tessa Therapeutics; TheraMyc
Other Relationship - Imedex; Medscape; MJH Life Sciences; Peerview; Physicans' Education Resource
 
Irene Brana
Consulting or Advisory Role - Achilles Therapeutics; Cancer Expert Now; eTheRNA Immunotherapies; Merck Sharp & Dohme; Rakuten Medical; Sanofi
Speakers' Bureau - Bristol-Myers Squibb; Merck Serono; Roche
Research Funding - AstraZeneca; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Gliknik; Janssen Oncology; Kura Oncology; Merck Sharp & Dohme; Nanobiotix; Novartis; Orion; Pfizer; Roche; Seagen (Inst); Shattuck Labs
Travel, Accommodations, Expenses - AstraZeneca Spain; Merck Serono
 
Elena Garralda
Consulting or Advisory Role - Alkermes; Anaveon; Boehringer Ingelheim; Bristol-Myers Squibb; Ellipses Pharma; Janssen; MAB Discovery; NeoMed; Roche; Seagen; TFS; Thermo Fisher Scientific
Speakers' Bureau - Lilly; MSD; Roche; Thermo Fisher Scientific
Research Funding - AstraZeneca/MedImmune; Novartis; Roche (Inst); Taiho Oncology (Inst); Thermo Fisher Scientific (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Glycotope GmbH; Menarini; Merck Sharp & Dohme